Scott-Macon Healthcare Review April 2021 Update
Providing our clients with senior level perspectives on corporate finance solutions in the healthcare industry.
Scott-Macon Healthcare Investment Banking Group presents our Healthcare Review for April 2021. The review includes expert insights from our senior professionals on:
- The record setting healthcare M&A volume through 2021 and our outlook for the remainder of 2021
- Deep dive into COVID’s impact on healthcare M&A over the last 16 months
- Spotlight on behavioral health M&A and investment in the wake of COVID induced long-term mental health issues
Based on more 30 years of transaction experience, our publications containing senior level perspectives are aimed at creating and advocating solutions to our clients in the healthcare industry to help them make informed investment decisions.